Angiotensin system-blocking medications are associated with fewer falls over 12 months in community-dwelling older people

Journal of the American Geriatrics Society

Volumn 61, Issue 5, 2013, Pages 776-781

  Wong, Alfred K W ^a   Lord, Stephen R ^a,b   Sturnieks, Daina L ^a   Delbaere, Kim ^a,b   Trollor, Julian N ^a,b   Close, Jacqueline C T ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

accidental falls; aged; cardiovascular medication; muscle strength; orthostatic hypotension

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CLINICAL TRIAL; CONTROLLED STUDY; FALLING; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; ORTHOSTATIC HYPOTENSION; QUADRICEPS FEMORIS MUSCLE; QUESTIONNAIRE; SEX; SIDE EFFECT;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MUSCLE STRENGTH; NEW SOUTH WALES; POSTURAL BALANCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; TIME FACTORS;

EID: 84878011257     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12205     Document Type: Article

References (30)

1. Campbell AJ, Borrie MJ, Spears GF,. Risk factors for falls in a community-based prospective study of people 70 years and older. J Gerontol A Biol Sci Med Sci 1989; 44A: M112-M117.
2. Ziere G, Dieleman JP, Hofman A, et al. Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol 2006; 61: 218-223.
3. Woolcott JC, Richardson KJ, Wiens MO, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009; 169: 1952-1960.
4. Leipzig RM, Cumming RG, Tinetti ME,. Drugs and falls in older people: A systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 1999; 47: 40-50.
5. Gribbin J, Hubbard R, Gladman JRF, et al. Risk of falls associated with antihypertensive medication: Population-based case-control study. Age Ageing 2010; 39: 592-597.
6. Yang S, Nguyen ND, Center JR, et al. Association between beta-blocker use and fracture risk: The Dubbo Osteoporosis Epidemiology Study. Bone 2011; 48: 451-455.
7. Onder G, Penninx BWJH, Balkrishnan R, et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: An observational study. Lancet 2002; 359: 926-930.
8. Sumukadas D, Witham M, Struthers A, et al. Effect of perindopril on physical function in elderly people with functional impairment: A randomized controlled trial. Can Med Assoc J 2007; 177: 867-874.
9. Gray SL, Boudreau RM, Newman AB, et al. Angiotensin-converting enzyme inhibitor and statin use and incident mobility limitation in community-dwelling older adults: The Health, Aging and Body Composition Study. J Am Geriatr Soc 2011; 59: 2226-2232.
10. Sachdev PS, Brodaty H, Reppermund S, et al. The Sydney Memory and Ageing Study (MAS): Methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years. Int Psychogeriatr 2010; 22: 1248-1264.
11. Delbaere K, Close JC, Heim J, et al. A multifactorial approach to understanding fall risk in older people. J Am Geriatr Soc 2010; 58: 1679-1685.
12. Moya A, Sutton R, Ammirati F, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009; 30: 2631-2671.
13. Lord SR, Menz HB, Tiedemann A,. A physiological profile approach to falls risk assessment and prevention. Phys Ther 2003; 83: 237-252.
14. Lamb SE, Jørstad EC, Hauer K, et al. Development of a common outcome data set for fall injury prevention trials: The Prevention of Falls Network Europe consensus. J Am Geriatr Soc 2005; 53: 1618-1622.
15. Scott D, Blizzard L, Fell J, et al. Statin therapy, muscle function and falls risk in community-dwelling older adults. Q J Med 2009; 102: 625-633.
16. Isaacs B,. Should we treat hypertension in the elderly? Age Ageing 1979; 8: 115-120.
17. Goodwin JS,. Embracing complexity: A consideration of hypertension in the very old. J Gerontol A Biol Sci Med Sci 2003; 58A: M653-M658.
18. Lakatta EG,. Age-associated cardiovascular changes in health: Impact on cardiovascular disease in older persons. Heart Fail Rev 2002; 7: 29-49.
19. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-1898.
20. Schmieder RE, Hilgers KF, Schlaich MP, et al. Renin-angiotensin system and cardiovascular risk. Lancet 2007; 369: 1208-1219.
21. Vijayaraghavan K, Deedwania P,. Renin-angiotensin-aldosterone blockade for cardiovascular disease prevention. Cardiol Clin 2011; 29: 137-156.
22. Ritter JM,. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension. BMJ 2011; 342: d1673.
23. Abuissa H, Jones PG, Marso SP, et al. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: A meta-analysis of randomized clinical trials. J Am Coll Cardiol 2005; 46: 821-826.
24. Prisant LM,. Management of hypertension in patients with cardiac disease: Use of renin-angiotensin blocking agents. Am J Med 2008; 8 (Suppl 1): S8-S15.
25. Camm AJ, Kirchhof P, Lip GYH, et al. Guidelines for the management of a trial fibrillation. Europace 2010; 12: 1360-1420.
26. Tomaschitz A, Pilz S, Ritz E, et al. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta 2010; 411: 1354-1360.
27. Baz-Hecht M, Goldfine AB,. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes 2010; 17: 113-119.
28. Rossitto G, Kamath G, Messerli FH,. Q: Should alpha-blockers ever be used as antihypertensive drugs? Cleve Clin J Med 2010; 77:884, 887-888.
29. Lakatta EG, Levy D,. Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises: Part I: Aging arteries: A "Set up" for vascular disease. Circulation 2003; 107: 139-146.
30. Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.